Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 17th July 2025
Solactive Global Health Services & Technology Americas:
In the ordinary adjustment, the following composition will be implemented effective open 17th July 2025:
ABBOTT LABORATORIES |
ABBVIE INC |
ADDUS HOMECARE CORP |
ALKERMES PLC |
AMEDISYS INC |
AMGEN INC |
BIOGEN INC |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CENTENE CORP |
CIGNA GROUP |
CONCENTRA GROUP HOLDINGS PARENT ORD |
DAVITA INC |
EDWARDS LIFESCIENCES CORP |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
FLEURY SA |
GILEAD SCIENCES INC |
HCA HEALTHCARE INC |
INCYTE CORP |
INNOVIVA INC |
INTEGER HOLDINGS CORP |
JOHNSON & JOHNSON |
LABCORP HOLDINGS INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERIT MEDICAL SYSTEMS INC |
NATIONAL HEALTHCARE CORP |
OPTION CARE HEALTH INC |
PFIZER INC |
PREMIER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
REDE D OR SAO LUIZ SA |
RESMED INC |
ROYALTY PHARMA PLC- CL A |
STERIS PLC |
STRYKER CORP |
SUPERNUS PHARMACEUTICALS INC |
U.S. PHYSICAL THERAPY INC |
VERTEX PHARMACEUTICALS INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |